News center

Owkin creates new spin out Waiv, formerly Owkin Dx, with $33m financing

Owkin creates new spin out Waiv, formerly Owkin Dx, with $33m financing

Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences

January 12, 2026

Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA

January 12, 2026

Owkin-Identified Biomarker-Defined Patient Subgroups In Phase 2 Trial Data Will Be Retrospectively Assessed By Servier

January 5, 2026

Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences

January 12, 2026

Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA

January 12, 2026

Explore

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

In the media

INSERM and Owkin sign an agreement to facilitate access to artificial intelligence for researchers

INSERM and Owkin sign an agreement to facilitate access to artificial intelligence for researchers

Le Quotidien du Medecin

In the media

Owkin raises $11M for its Series A financing round

January 16, 2018

Owkin raises $11M for its Series A financing round

January 16, 2018